JPS6312065B2 - - Google Patents

Info

Publication number
JPS6312065B2
JPS6312065B2 JP1721979A JP1721979A JPS6312065B2 JP S6312065 B2 JPS6312065 B2 JP S6312065B2 JP 1721979 A JP1721979 A JP 1721979A JP 1721979 A JP1721979 A JP 1721979A JP S6312065 B2 JPS6312065 B2 JP S6312065B2
Authority
JP
Japan
Prior art keywords
group
formula
cells
lower alkylamino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP1721979A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55111470A (en
Inventor
Kazuya Sasaki
Yukio Inoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP1721979A priority Critical patent/JPS55111470A/ja
Priority to US06/109,314 priority patent/US4261989A/en
Priority to AU54430/80A priority patent/AU532333B2/en
Priority to GB8001321A priority patent/GB2042523B/en
Priority to FR8002589A priority patent/FR2449084A1/fr
Priority to NL8000857A priority patent/NL8000857A/nl
Priority to CA345,489A priority patent/CA1113935A/en
Priority to DE19803006097 priority patent/DE3006097A1/de
Priority to IT20017/80A priority patent/IT1147315B/it
Publication of JPS55111470A publication Critical patent/JPS55111470A/ja
Publication of JPS6312065B2 publication Critical patent/JPS6312065B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1721979A 1979-02-19 1979-02-19 Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient Granted JPS55111470A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP1721979A JPS55111470A (en) 1979-02-19 1979-02-19 Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient
US06/109,314 US4261989A (en) 1979-02-19 1980-01-03 Geldanamycin derivatives and antitumor drug
AU54430/80A AU532333B2 (en) 1979-02-19 1980-01-08 Geldanamycin derivatives
GB8001321A GB2042523B (en) 1979-02-19 1980-01-15 Geldanamycin derivatives and anti-tumor drug
FR8002589A FR2449084A1 (fr) 1979-02-19 1980-02-06 Nouveaux derives de geldanamycine, leur procede de preparation et leur application en therapeutique
NL8000857A NL8000857A (nl) 1979-02-19 1980-02-12 Geldanamycinederivaten, werkwijze voor het bereiden hiervan en de toepassing als geneesmiddel.
CA345,489A CA1113935A (en) 1979-02-19 1980-02-13 Geldanamycin derivatives and antitumor drug
DE19803006097 DE3006097A1 (de) 1979-02-19 1980-02-19 Geldanamycinderivate und antitumormittel mit einem gehalt derselben
IT20017/80A IT1147315B (it) 1979-02-19 1980-02-19 Derivati della geldanamicina e farmaci antitumorali

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1721979A JPS55111470A (en) 1979-02-19 1979-02-19 Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient

Publications (2)

Publication Number Publication Date
JPS55111470A JPS55111470A (en) 1980-08-28
JPS6312065B2 true JPS6312065B2 (en]) 1988-03-17

Family

ID=11937822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1721979A Granted JPS55111470A (en) 1979-02-19 1979-02-19 Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient

Country Status (1)

Country Link
JP (1) JPS55111470A (en])

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0457021U (en]) * 1990-09-10 1992-05-15

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002079167A1 (en) 2001-03-30 2002-10-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Geldanamycin derivative and method of treating cancer using same
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
US7259156B2 (en) 2004-05-20 2007-08-21 Kosan Biosciences Incorporated Geldanamycin compounds and method of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0457021U (en]) * 1990-09-10 1992-05-15

Also Published As

Publication number Publication date
JPS55111470A (en) 1980-08-28

Similar Documents

Publication Publication Date Title
US20140187576A1 (en) Salt of naphthyridine carboxylic acid derivative
EP0486565B1 (en) Discodermolide compounds, compositions containing same and methods of preparation and use
RU2467012C2 (ru) Способ очистки стауроспорина и способ получения n-бензоилстауроспорина
KR20150027217A (ko) 항진균성 항생 암포테리신 b의 n-치환된 제2 세대 유도체, 및 이의 제조 및 응용 방법
EP0313874B1 (en) Disulfur analogs of LL-E33288 antitumor agents
EP2959040A2 (en) Target binding molecules identified by kinetic target-guided synthesis
IE52717B1 (en) Novel indanyl derivatives and their manufacture and use
JPS6312065B2 (en])
JPS642593B2 (en])
EP0787494B1 (en) Use of rifamycin derivatives for the manufacture of a medicament for the treatment of diseases caused by infections of helicobacter pylori
KR101208956B1 (ko) 엘로티닙 다이클로로아세트산염 및 이를 포함하는 항암제 조성물
EP0080819A1 (en) 11-0-Alkylerythromycin A derivatives
JPS6334866B2 (en])
JPS6341885B2 (en])
JPS6312066B2 (en])
IE881600L (en) Tetrahydrofurans and tetrahydrothiophenes
AU2004232495B2 (en) 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo [2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms
FI80440B (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara afidkolanderivat.
DE69314947T2 (de) 2-aminozuckermakrolid-derivate
US3884902A (en) Sulfonyl derivatives of erythromycin
EP1124831B1 (en) Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation
CN110964084B (zh) 一种那西肽衍生物及其制备方法
JPH07108909B2 (ja) 新規な２▲’▼−置換−４−デオキシ−チアゾロ〔５，４−ｃ〕−リフアマイシンＳＶ誘導体
CN111196839B (zh) 一种硫链丝菌素衍生物及其制备方法
JPS6219430B2 (en])